Abstract:Abstract Background N6-methyladenosine (m6A) RNA methylation plays a critical role in key genetic events for various cancers; yet, how m6A functions within the tumor microenvironment (TME) remains to be elucidated. Methods A total of 65,362 single cells from single-cell RNA-seq data derived from 33 CRC tumor samples were analyzed by nonnegative matrix factorization (NMF) for 23 m6A RNA methylation regulators. CRC and Immunotherapy cohorts from public repository were used to determine the prognosis and immune response of TME clusters. Results The fibroblasts, macrophages, T and B cells were respectively grouped into 4 to 5 subclusters and then classified according to various biological processes and different marker genes. Furthermore, it revealed that the m6A RNA methylation regulators might be significantly related to the clinical and biological features of CRC, as well as the pseudotime trajectories of main TME cell types. Bulk-seq analysis suggested that these m6A-mediated TME cell subclusters had significant prognostic value for CRC patients and distinguished immune response for patients who underwent ICB therapy, especially for the CAFs and macrophages. Notably, CellChat analysis revealed that RNA m6A methylation-associated cell subtypes of TME cells manifested diverse and extensive interaction with tumor epithelial cells. Further analysis showed that ligand-receptor pairs, including MIF − (CD74 + CXCR4), MIF − (CD74 + CD44), MDK–NCL and LGALS9 − CD45, etc. mediated the communication between m6A associated subtypes of TME cells and tumor epithelial cells. Conclusions Taken together, our study firstly revealed the m6A methylation mediated intercellular communication of the tumor microenvironment in the regulation of tumor growth and antitumor immunomodulatory processes.

The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications

Single-cell N6-methyladenosine Regulator Patterns Guide Intercellular Communication of Tumor Microenvironment That Contribute to Colorectal Cancer Progression and Immunotherapy

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

Roles of METTL3 in Cancer: Mechanisms and Therapeutic Targeting

Unraveling the independent role of METTL3 in m6A modification and tumor progression in esophageal squamous cell carcinoma

Insights into roles of METTL14 in tumors

METTL3 plays a crucial function in multiple biological processes

M6A "Writer" Gene <i>METTL14</i>: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer

The role of RNA methylation in tumor immunity and its potential in immunotherapy

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy

Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer

The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis

Critical Roles of METTL3 in Translation Regulation of Cancer

Multiple functions and mechanisms underlying the role of METTL3 in human cancers

The Role of RNA Methyltransferase METTL3 in Hepatocellular Carcinoma: Results and Perspectives

Methyltransferase-like Proteins in Cancer Biology and Potential Therapeutic Targeting

Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application

The Evolving Landscape of N6-methyladenosine Modification in the Tumor Microenvironment.